Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Mining Corp.

http://www.molecularmining.com/

Latest From Molecular Mining Corp.

Recent Dealmaking (02/2003)

Summarizing the month in European dealmaking.

Of Mice and Men: Predictive Toxicology

Current in vivo and in vitro models can't keep up with the demand for the safety assessment of large numbers of compounds emerging from high-throughput strategies. Pharmaceutical companies and start-ups are therefore building new systems that they hope will be capable of predicting the toxicity liabilities of new compounds. Cheminformatics can help week out toxic compounds at the lead selection and optimization stage; toxicogenomics may provide a toxicity diagnostic capability at all stages of drug development. For both toxicology approaches, there is not yet enough high quality data to build predictive models. Toxicology-focused cheminformatics programs attempt to consolidate data from hitherto untapped sources; toxicogenomics companies are engaged in the fussy and expensive process of manufacturing data from scratch and validating them with biological experiments.

Clinical Trials Regulation

Molecular Mining Corp.

Molecular Mining Corp. bills itself as an expert in KDD or "knowledge discovery and data mining." The company's first offering will likely address gene expressoin data. Scientists believe that proper statistical analysis of the data should reveal genes that are co-regulated, and possibly even entire regulatory pathways.

BioPharmaceutical Research and Development Strategies

Data Mining

Data mining is the neologism given to the tools of pattern recognition and discovery, themselves a grab bag of mathematical methods used to glean information from complex or noisy data sets. If the number of start-ups like Silicon Genetics is any measure, the pharmaceutical industry looks like data mining's next big market.

BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Services
  • Biotechnology
    • Drug Discovery Tools
    • Drug Discovery Tools
      • Bioinformatics
UsernamePublicRestriction

Register